MCKESSON CORP (MCK) Stock Price & Overview
NYSE:MCK • US58155Q1031
Current stock price
The current stock price of MCK is 862.048 USD. Today MCK is down by -2.51%. In the past month the price decreased by -5.05%. In the past year, price increased by 29.45%.
MCK Key Statistics
- Market Cap
- 105.592B
- P/E
- 22.94
- Fwd P/E
- 19.29
- EPS (TTM)
- 37.58
- Dividend Yield
- 0.38%
MCK Stock Performance
MCK Stock Chart
MCK Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to MCK. When comparing the yearly performance of all stocks, MCK is one of the better performing stocks in the market, outperforming 72.81% of all stocks.
MCK Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MCK. Both the profitability and the financial health of MCK get a neutral evaluation. Nothing too spectacular is happening here.
MCK Earnings
On February 4, 2026 MCK reported an EPS of 9.34 and a revenue of 106.16B. The company beat EPS expectations (0.33% surprise) and missed revenue expectations (-0.71% surprise).
MCK Forecast & Estimates
22 analysts have analysed MCK and the average price target is 1000.04 USD. This implies a price increase of 16.01% is expected in the next year compared to the current price of 862.048.
For the next year, analysts expect an EPS growth of 19.08% and a revenue growth 12.74% for MCK
MCK Groups
Sector & Classification
MCK Financial Highlights
Over the last trailing twelve months MCK reported a non-GAAP Earnings per Share(EPS) of 37.58. The EPS increased by 28.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.09% | ||
| ROA | 5.16% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MCK Ownership
MCK Latest News, Press Relases and Analysis
MCK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| COR | CENCORA INC | 16.18 | 63.183B | ||
| CAH | CARDINAL HEALTH INC | 18.2 | 50.37B | ||
| HSIC | HENRY SCHEIN INC | 13.74 | 8.481B | ||
| AHCO | ADAPTHEALTH CORP | 12.08 | 1.635B | ||
| ACH | ACCENDRA HEALTH INC | 4.84 | 201.037M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 9.108M |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MCK
Company Profile
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
Company Info
IPO: 1994-11-10
MCKESSON CORP
6555 State Highway 161
Irving TEXAS 75039 US
CEO: Brian S. Tyler
Employees: 43000
Phone: 18009279800
MCKESSON CORP / MCK FAQ
What does MCKESSON CORP do?
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
What is the current price of MCK stock?
The current stock price of MCK is 862.048 USD. The price decreased by -2.51% in the last trading session.
Does MCKESSON CORP pay dividends?
MCKESSON CORP (MCK) has a dividend yield of 0.38%. The yearly dividend amount is currently 2.71.
What is the ChartMill rating of MCKESSON CORP stock?
MCK has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for MCK stock?
22 analysts have analysed MCK and the average price target is 1000.04 USD. This implies a price increase of 16.01% is expected in the next year compared to the current price of 862.048.
Would investing in MCKESSON CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MCK.
Can you provide the market cap for MCKESSON CORP?
MCKESSON CORP (MCK) has a market capitalization of 105.59B USD. This makes MCK a Large Cap stock.